Sector:
Healthcare

Location:
Lexington, MA

Year Funded:
2004

Status:
Active

Website:
www.inotekcorp.com

Summary:
Inotek is a drug development company advancing innovative drug candidates to address significant diseases of the eye, with a major focus on glaucoma. Inotek’s lead drug candidate INO-8875 is a potential first-in-class treatment for glaucoma and ocular hypertension that significantly reduced intraocular pressure (IOP) in glaucoma subjects following single ocular doses in a Phase 1/2 clinical trial.